ABO and Alzheimer disease: Furthermore, as changes in lysosome size was described in APP mouse transgenic model of Alzheimer’s disease (Gowrishankar et al., 2015), we asked whether detectable changes in lysosome diameter can be quantified on 24- or 48-h exposure to 1 μm AβF and AβO.